key: cord-0974905-jblh5m49 authors: Zhao, X.; Lei, Z. title: The Impact of Coronavirus Disease 2019 (COVID-19) on Liver Injury in China: A Systematic Review and Meta-analysis date: 2020-05-08 journal: nan DOI: 10.1101/2020.05.03.20089557 sha: c48d5639deeddd9ccffbef0013f7731789c69c3c doc_id: 974905 cord_uid: jblh5m49 Abstract Background: The evidence for the incidence and severity of liver injury in Chinese patients with COVID-19 is still controversial. Aims: The purpose of this study was to summarize the incidence of liver injury and the differences between liver injury markers among different patients with COVID-19 in China. Methods: Computer searches of PubMed, Embase, CNKI and medRxiv were used to obtain reports on the incidence and markers of liver injury in Chinese patients with COVID-19, from January 1, 2020 to April 10, 2020. (No. CRD42020181350) Results: A total of 57 reports from China were included, including 9889 confirmed cases of COVID-19 infection. The results of the meta-analysis showed that among the patients with early COVID-19 infection in China, the incidence of liver injury events was 24.7% (95% CI, 23.4%-26.4%). Liver injury in severe patients was more common than that in non-severe patients, with a risk ratio of 2.07 (95% CI, 1.77 to 2.43). Quantitative analysis showed that the severe the coronavirus infection, the higher the level of AST, ALT, TB, ALP, GGT and the lower the level of ALB. The changing trend of the appeal index was similar in ICU patients and dead patients. Conclusion: There is a certain risk of liver injury in Chinese patients with COVID-19, and the risk and degree of liver injury are related to the severity of COVID-19. In December 2019, an unexplained viral pneumonia broke out in Wuhan, China, and the World Health Organization named it COVID-19 [1] . As of April 20, 2020, the cumulative incidence of global COVID-19 has exceeded 2 million, and the number of death is close to 200000 [1] [2] [3] . Studies have shown that the pathogen of COVID-19 is β -coronavirus, and its gene sequence is highly similar to that of SARS and MERS [4] . The source and specific route of transmission of the virus are still unclear. The principal target organ of COVID-19 is the human lung, and some studies have shown that the virus can damage the heart, liver, nervous system, and so on [5] [6] [7] . Liver injury was also noted in SARS and MERS. Guan (158/741). Among the 99 cases reported by Chen et al, there were 43 cases of abnormal liver function. These findings seemed to imply that there was a definite relationship between novel coronavirus and liver injury [8] [9] [10] . However, the effect of COVID-19 on liver injury is still unclear and requires further study. All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which COVID-19 liver injury [9, 10] . At present, there is no systematic review or meta-analysis of the effects of COVID-19 on liver injury, so the purpose of this study is to perform a meta-analysis to systematically review and analyse the effects of COVID-19 on liver injury in China to provide some reference for clinical practice.. The systematic review and meta-analysis has been registered on Prospero (Registration number CRD42020181350; https://www.crd.york.ac.uk/PROSPERO). We reported this systematic review and meta-analysis according to MOOSE guidelines and PRISMA [11, 12] . Three electronic databases, PubMed, Embase, CNKI and the medRxiv system (https://www.medrxiv.org), were searched by our team. The keywords included "coronavirus", "nCoV", "SARS-CoV-2", "COVID", "COVID-19", "NCP" and "China". All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We screened the retrieved literature, and the eligible study was to report the occurrence of liver injury or the abnormal rise or abnormal changes of biochemical markers of liver injury (AST, ALT, TB and so on), and the original data should come from China. We selected studies that met the following inclusion criteria: (1) nucleic acid-confirmed and clinically confirmed COVID-19 patients; (2) reported studies of liver injury events or liver injury markers; (3) the language was confined to English or Chinese; (4) the source of the research was limited to China; (5) the retrieval time was limited from January 1, 2020 to April 10, 2020. If the research was from multiple centres, we tried to divide it into a single centre for analysis. If there were multiple studies on the same team, the latest research from the team was used for analysis. The following studies were excluded: (1) COVID-19 patients without nucleic acid diagnosis or clinical diagnosis; (2) reports of special groups such as pregnant women and children; (3) studies that only report deaths or critically ill patients; (4) studies that do not report liver injury events or markers of liver injury; (5) research reports that the participants are not from China. All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which complications, use of therapeutic drugs, events of liver injury, changes in markers of liver injury, and differences in the process of data extraction. Disagreements were settled by discussion of all the investigators. We used the Newcastle-Ottawa Quality Assessment Scale for retrospective studies to assess the methodological quality of included studies. We used stata16.0 for data analysis. We define liver injury as AST or ALT or TB above the upper limit, as if there are three or two items of data in a study. The term with the highest number of events was used as the analytical data. If the P-value of liver injury is 0.3 to 0.7, meta-analysis was carried out directly; on the contrary, the data were converted by Freeman-Tukey double arcsine transformation to make them in accordance with a normal distribution and then analysed and combined [13] . All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The ultimate result after data conversion was restored by using the formula P = [sin (tp/2)] 2 . The degree of heterogeneity was evaluated by the Q 2 and I 2 indexes. I 2 is low heterogeneity when it is 0% to 25%, moderate heterogeneity when it is 26% to 75%, and high heterogeneity when it is 76% to 100%. The fixed effect model was used when I 2 < 25% P > 0.1; if I 2 ≥ 25% or P ≤ 0.1, the random effect model was used. If only the median and quartile ranges (Q25 and Q75) were reported, then we assumed that the median was equivalent to the average, and the standard deviation (SD) is (Q75-Q25)/2. We also performed a subgroup analysis of the results with heterogeneity, and publication bias was evaluated by Bgger's test. A bilateral P-value less than or equal to 0.05 was regarded as statistically significant. 4065 articles were obtained by preliminary search, 3754 articles were obtained after repetition, 3478 reading topics and abstracts were excluded, and 274 full-text articles were excluded. After discussion, the three authors (ZX, LZH, GFW) excluded 217 articles, and finally included 57 studies [2, 9, 10, , all of which were retrospective studies. The detailed search and study selection process are shown in Figure. 1. Thirty-five articles were published in public journals, and 22 were All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Of the 57studies, 23 were from Wuhan and 34 were not from Wuhan. Among them, 5 items were compared between death and survival patients, 4 items were compared between ICU and non-ICU patients, and 39 items were reported between severe patients and non-severe patients, of which the diagnosis of severe and non-severe cases was based on the diagnosis and treatment of pneumonia caused by COVID-19 in China, edition 1-5. A total of 9889 patients diagnosed with COVID-19 were enrolled. The source of the cases was primarily from January to February 2020. Among them, 4606 were male, 4629 were female, and 1618 were critically ill patients. The main comorbidities included hypertension, diabetes, liver disease, and so on. Drug treatment was mainly antibiotics and antivirals. Some studies reported treatment using traditional Chinese medicine, which is shown in Table 1 . The Newcastle-Ottawa scale (NOS) was used to evaluate the quality of retrospective studies, the results of NOS score is also shown in Table 1 . A total of 33 studies reported liver injury events, and 5867 COVID-19 patients reported liver injury events. The All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which Table 2 ). Eleven studies reported the occurrence of liver injury caused by increased ALT in severe and non-severe patients, suggesting that the risk of liver injury in severe COVID-19 patients was 1.69 times higher than that in non-severe patients Figure 4 ). The funnel chart is symmetrical (Supplementary Material, Figure 5 ). (Supplementary Material , Overall Summary of Results Table 2 ). In the comparative study of severe and non-severe COVID-19, 27 studies showed that the ALT(U/L) of severe patients Figure 8 ). There were seven reports of ALP(U/L) comparisons, and the results showed that the ALP of severe All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which The funnel plot and Bgger test showed no publication bias for rate of liver injury ( Figure 3 and Table 2 ), the relationship between the severity of COVID-19 and the incidence of liver injury ( Figure 5 and Table 2 ) and the relationship between All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. COVID-19 and the degree of liver injury (Table 2) . Forest plot showed little sensitivity change by systematically removing each study for rate of liver injury, the relationship between the severity of COVID-19 and the incidence of liver injury, the relationship between COVID-19 and the degree of liver injury. In this systematic review and meta-analysis, we found that the incidence of liver injury in Chinese COVID-19 patients was 24.7%, and the incidence of liver injury in Wuhan was slightly higher than that in non-Wuhan patients. At present, the mechanism of liver injury in patients with COVID-19 includes SARS-CoV-2 virus directly attacking liver tissue, and the target receptor of SARS-CoV-2 is the ACE2 receptor. However, previous studies have shown that the ACE2 receptor is highly expressed in intrahepatic bile duct epithelial cells but is expressed at low levels in hepatocytes [68, 69] . Therefore, it is possible for the SARS-CoV-2 virus to directly damage the intrahepatic biliary system, but it is less likely to directly damage hepatocytes. In our study, we also found that GGT is a marker of bile duct injury. ALP increased, but only 7 cases were reported. The mechanism of secondary liver injury includes the inflammatory storm effect caused by systemic inflammation, drug factors and multiple organ dysfunction caused by hypoxia. A meta-analysis by Wang et al [70] concluded All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. reported that the total prevalence rate of COVID-19 in patients with chronic liver disease was only 3%. Two other studies reported that liver injury markers in mild patients were at normal levels, which seemed to suggest that COVID-19 was less likely to directly damage the liver [2, 46] . In our study, we observed that the incidence of liver injury and AST, ALT, TB, GGT, and ALP quantitative analysis of liver injury markers in severe patients were higher than those in non-severe patients, while the quantity of ALB in severe patients was lower than that in non-severe patients. The trend of ICU was similar to that of non-ICU patients. This conclusion is consistent with the clinical characteristics of patients with COVID liver injury analysed by Qi et al [7] . All these findings suggest that the more serious the COVID infection, the higher the risk of liver injury and the more severe the injury. The more intense the infection symptoms of critically ill patients are, the greater the impact of the storm of inflammatory factors on liver function. In addition, most of patients included in the study were diagnosed between January and February 2020, who were treated promptly, when the drug treatment of critically ill patients is often uncertain, and antiviral, antibiotic, and traditional Chinese medicine treatments are often combined. It will cause some damage to liver All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. function. Additionally, patients with severe COVID-19 often have hypoxemia, which leads to hepatocyte ischaemia and hypoxia, and multiple organ failure may also be one of the causes of liver damage. Therefore, secondary liver injury is more common in critically ill patients, but the possibility of direct liver injury caused by COVID-19 cannot be ruled out. Therefore, in critically ill patients, real-time monitoring of liver function, evaluation of liver injury, and inexpensive choice of drug treatment are necessary. We also included four analyses of liver damage in dead and surviving COVID-19 patients. Changes in liver injury markers were similar to those of severe and non-severe patients. Owing to data limitations, we did not further analyse whether liver injury increases the risk of death in patients with COVID-19. Our study also has some limitations. First, although there is no obvious bias in the definition of liver injury and detection of liver injury markers, some of the results are still heterogeneous. Second, this study only analysed the data of Chinese COVID-19 patients, not remote data analysis. Third, it is not possible to further describe the effects of other confounding factors, such as complications, age, and gender, on the results of the study; these confounding factors are also difficult to adjust. Fourth, most of the included studies are retrospective analyses, some are cross-sectional studies, 22 are manuscripts that have not been peer-reviewed, and there is a danger of bias in data collection. All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Conclusion: There is a certain risk of liver injury in Chinese patients with COVID-19, and the risk and degree of liver injury are related to the severity of COVID-19. Nothing to declare. All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Clinical features of patients infected with 2019 novel coronavirus in Wuhan Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet Cardiac Involvement in a Patient With Coronavirus Disease No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases Clinical Characteristics of Coronavirus Disease 2019 in China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration Meta-analysis of observational studies in epidemiology: a proposal for reporting All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Meta-analysis of prevalence Characteristics of Liver Tests in COVID-19 Patients Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease Clinical Features of Patients Infected with the 2019 Novel Coronavirus Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019. medRxiv Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia Clinical features and management of severe COVID-19: A retrospective study in Wuxi Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Clinical characteristics of 80 patients with COVID-19 in Zhuzhou City Risk factors related to hepatic injury in patients with corona virus disease 2019. medRxiv Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study Chin Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv A descriptive study of the impact of diseases control and prevention on the epidemics All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint doi: medRxiv preprint dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan Clinical characteristics of refractory COVID-19 pneumonia in Wuhan Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Manifestations of liver injury in 333 hospitalized patients with coronavirus disease Epidemiological and clinical characteristics of 46 newly-admitted coronavirus disease 2019 cases in Beijing Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study Analysis of clinical characteristics of 49 patients with coronavirus disease Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Clinical characteristics, treatment, and prognosis in 89 cases of COVID-2019 Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Clinical Characteristics of Coronavirus Disease Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in China: a single-centered, retrospective, observational study Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint A retrospective analysis of the clinical characteristics of 223 NCP patients in Chongqing Liver injury in COVID-19: management and challenges Clinical features and outcomes of 221 patients with COVID-19 in Wuhan Clinical characteristics of 74 hospitalized patients with COVID-19 Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei Clinical characteristics of 161 cases of corona virus disease Clinical features and outcomes of 197 adult discharged patients with COVID-19 in Yichang Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder